Flagship versatility for the lab: Avantor J.T.Baker BAKERBOND WP HIC butyl column in focus for biomolecule purification

Avantor’s J.T.Baker BAKERBOND WP HIC butyl preparative column targets downstream purification of proteins and other biomolecules that are sensitive to denaturation, aiming to give process developers a robust, scalable flagship option for hydrophobic interaction chromatography in regulated environments.

Edited by ad hoc news Flagship & Bestseller Desk. Reviewed before publication on 06/15/2026 at 10:53 AM ET. Details in the imprint.

Hydrophobic interaction chromatography remains a workhorse for polishing therapeutic proteins, and Avantor’s J.T.Baker BAKERBOND WP HIC butyl preparative column is positioned as a flagship option for labs that need scalable, reproducible separations without sacrificing biomolecule integrity. The column uses a wide-pore base matrix and butyl ligand chemistry to separate proteins, peptides and other biomolecules under relatively mild, non-denaturing conditions, which is critical for maintaining native structure and activity during downstream purification. According to Avantor product documentation, the wide-pore design is optimized for large biomolecules such as monoclonal antibodies and enzyme conjugates, while the butyl functional group balances retention strength with elution flexibility across varying salt gradients and pH ranges. The column is marketed as suitable for process development and scale-up in biopharmaceutical workflows where robustness and regulatory compatibility are central concerns. To support these use cases, Avantor specifies that the BAKERBOND WP HIC butyl phase is built on a mechanically stable support that can withstand typical pressures and cleaning-in-place cycles encountered in preparative liquid chromatography.

How the BAKERBOND WP HIC butyl column is built for real-world purification

At its core, the J.T.Baker BAKERBOND WP HIC butyl column is based on a wide-pore, hydrophilic support onto which butyl ligands are covalently bonded, creating a moderately hydrophobic surface that interacts with exposed hydrophobic regions of proteins when high concentrations of lyotropic salts are present. When a protein mixture is loaded under high salt, more hydrophobic species bind more strongly to the column, while less hydrophobic components elute earlier; a subsequent decrease in salt concentration or change in buffer composition then weakens these interactions, allowing controlled elution of target molecules in order of hydrophobicity. This operating principle allows process developers to fine-tune resolution between closely related isoforms, aggregates or degradation products by adjusting gradient shape, salt type and temperature, using standard HIC method-development approaches familiar to chromatographers.

Avantor emphasizes that the wide-pore structure of the BAKERBOND WP HIC butyl packing is designed to accommodate large biomolecules such as monoclonal antibodies, fusion proteins and virus-like particles, reducing the risk of diffusion limitations that can impair mass transfer and peak shape. In manufacturer materials, the BAKERBOND WP HIC portfolio is described as providing consistent performance across a range of column dimensions, which is important when moving from analytical scouting columns to preparative formats used for pilot-scale or small commercial batches. The support material is engineered for mechanical stability to handle common system backpressures and repeated gradient cycles, while the surface chemistry is optimized to minimize non-specific interactions that can lead to tailing or recovery losses. According to Avantor, these characteristics make the butyl phase particularly suitable for polishing steps after initial capture, where the objective is to remove aggregates, misfolded variants and process-related impurities while preserving the activity of the drug substance. In many biologics workflows, HIC complements ion-exchange and size-exclusion chromatography, and a robust HIC step can be decisive for hitting critical quality attributes such as aggregation levels and charge variant profiles.

In practical terms, process scientists evaluating the J.T.Baker BAKERBOND WP HIC butyl column will focus on parameters such as dynamic binding capacity at relevant conductivities, pressure-flow characteristics and cleaning-in-place compatibility with solutions like sodium hydroxide or chaotropic agents. Avantor’s technical documentation highlights that the BAKERBOND HIC materials are compatible with commonly used buffers and sanitizing conditions, allowing integration into existing process chromatography skids without major hardware changes. The resin’s butyl ligand density and uniformity are tuned to provide predictable retention and scalable resolution across column sizes, which helps simplify method transfer from small development columns to production-relevant formats. For quality and regulatory teams, the availability of detailed certificates of analysis, extractables information and manufacturing traceability from Avantor can support validation activities in Good Manufacturing Practice environments. These factors, combined with global distribution of J.T.Baker branded products, position the BAKERBOND WP HIC butyl column as a mainstream choice for labs that need supply-chain reliability alongside technical performance.

From a portfolio perspective, the BAKERBOND WP HIC butyl preparative column sits alongside other J.T.Baker chromatography offerings that span ion-exchange, reversed-phase and affinity chemistries, giving customers the option to source multiple purification steps from a single vendor. This can simplify vendor qualification and may improve compatibility between resins when designing multi-step downstream processes. Avantor’s focus on bioprocessing solutions means that the company also offers complementary products such as buffers, single-use systems and lab consumables that can be paired with BAKERBOND columns to build out complete purification platforms. For biopharma customers, having a chromatography resin that is available in different formats and supported by technical application guidance can reduce development time when bringing new biologics from preclinical stages through clinical manufacturing. While specific binding capacity figures, pressure limits and lot-to-lot variability metrics are typically assessed case by case during vendor qualification, the J.T.Baker brand’s long-standing presence in chromatography is a factor process teams routinely consider when standardizing on resins for multiple projects.

Avantor does not position the BAKERBOND WP HIC butyl column as a niche specialty product but rather as a broadly applicable workhorse for hydrophobic interaction steps in research and regulated manufacturing. That positioning reflects the widespread need for HIC in antibody, vaccine and enzyme production, where fine control over aggregate content and hydrophobic variants can have direct implications for safety and efficacy. In this context, process developers evaluating HIC options often weigh resin performance against supply security, documentation depth and global support, areas where global suppliers such as Avantor typically emphasize their footprint. The J.T.Baker BAKERBOND WP HIC butyl column therefore fits into a category of flagship, high-volume chromatography consumables that are used across therapeutic modalities as well as in industrial enzymes and diagnostics manufacturing. For labs planning long-running programs, the expectation is that such resins will remain available with minimal formulation changes over many years, enabling stable, validated processes.

Within Avantor’s overall business, chromatography media and bioprocessing consumables form part of a broader portfolio that supports life sciences, advanced technologies and applied materials markets. These product lines contribute to recurring revenue streams driven by ongoing lab and production usage rather than one-off capital purchases, making consumables like BAKERBOND WP HIC butyl strategically significant even if individual SKUs are not publicly broken out in financial reporting. Shares of Avantor (US05352A1007) traded on the New York Stock Exchange at around $24 in mid-June 2026, reflecting investor focus on the company’s ability to grow its biopharma consumables and services franchise within a competitive life-science tools landscape.

J.T.Baker BAKERBOND WP HIC butyl column in brief

• Product: J.T.Baker BAKERBOND WP HIC butyl preparative column
• Manufacturer: Avantor, Inc.
• Category: Flagship/Bestseller
• Launch date: Not publicly specified; available as an established catalog product
• MSRP / Price: Varies by column dimension and configuration; typically quoted on request from Avantor or distributors
• Availability: Available through Avantor sales channels and authorized distributors in North America, Europe and other key biopharma regions
• Target audience: Biopharmaceutical process developers, manufacturing scientists and analytical labs working on protein, antibody and enzyme purification
• Key differentiator / USP: Wide-pore, butyl-based hydrophobic interaction phase designed for scalable, non-denaturing purification of large biomolecules in preparative chromatography workflows

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.